Terns Pharmaceuticals
TERN
TERN
65 hedge funds and large institutions have $505M invested in Terns Pharmaceuticals in 2022 Q4 according to their latest regulatory filings, with 25 funds opening new positions, 23 increasing their positions, 14 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
65
Holders Change
+20
Holders Change %
+44.44%
% of All Funds
1.05%
Holding in Top 10
5
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+150%
% of All Funds
0.08%
New
25
Increased
23
Reduced
14
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
![]()
1
Fidelity Investments
Boston,
Massachusetts
|
$75.1M |
2 |
SCM
2
Suvretta Capital Management
New York
|
$35.1M |
3 |
3
Millennium Management
New York
|
$14.8M |
4 |
RI
4
RTW Investments
New York
|
$10.2M |
5 |
DM
5
Deerfield Management
New York
|
$29M |
Top Sellers
1 |
IC
1
Ikarian Capital
Dallas,
Texas
|
$7.51M |
2 |
2
Barclays
London,
United Kingdom
|
$5.26M |
3 |
PVI
3
Pura Vida Investments
New York
|
$6.16M |
4 |
CC
4
Commodore Capital
New York
|
$0 |
5 |
SB
5
Samsara BioCapital
Palo Alto,
California
|
$2.06M |